Marina García-Prat

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi et al. · Frontiers in Immunology · 2018 · 182 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

Julian Thalhammer, Gerhard Kindle, Alexandra Nieters et al. · Journal of Allergy and Clinical Immunology · 2021 · 170 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

Victoria K. Tesch, Hassan Abolhassani, Bella Shadur et al. · Journal of Allergy and Clinical Immunology · 2019 · 161 citations · Full text

Medicine, Hematology, Immunology +12